As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes. To read the full article, click here

Established in 2001 in partnership with St George’s University of London, Richmond Pharmacology’s aim was to create a structure where practising physicians were actively involved in clinical research. Profits were reinvested into the business or used to fund academic research in underfunded areas - leading to the creation of Richmond Research Institute in 2020.

Two decades later and the landscape of early phase clinical research has changed dramatically. Moving from small molecules whose effects were studied for numerous medical conditions to therapeutics such as mRNA, siRNA, and gene editing which treat specific disease pathways. 

This progressive course of education and regulatory environment must continue if we are to align with the advancements in precision medicine. 

Read Dr Taubel’s full reflection in the PharmaTimes.

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more


13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event